Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02232282 · ClinicalTrials.gov registry record · NA
Acupuncture for Female IC/PBSyndrome and Its Effect on the Urinary Microbiome: A Randomized Controlled Trial
A NA study, sponsored by Loyola University.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT02232282 is a NA study that has completed, run by Loyola University. The registered enrollment target is 22 participants.
The verdict
NCT02232282, a NA study, has completed, sponsored by Loyola University.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
The investigators central hypothesis is that women with Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS) will benefit from acupuncture compared with sham treatment and acupuncture responders will have a differential urinary microbiome.
Interventions
- DEVICE standard acupuncture treatment
- DEVICE Control Sham/Minimal Acupuncture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2014-10 |
| Est. Completion | 2017-08-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02232282
The ClinicalTrials.gov registry entry for NCT02232282 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loyola University, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which standard acupuncture treatment is the first listed.
NCT02232282 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02232282 about?
NCT02232282 is a clinical study titled "Acupuncture for Female IC/PBSyndrome and Its Effect on the Urinary Microbiome: A Randomized Controlled Trial". The investigators central hypothesis is that women with Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS) will benefit from acupuncture compared with sham treatment and acupuncture responders will have a differential urinary microbiome.
What is the current status of trial NCT02232282?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2014-10. Estimated completion is 2017-08-16.
What interventions are being tested in trial NCT02232282?
The interventions under investigation include: standard acupuncture treatment (DEVICE), Control Sham/Minimal Acupuncture (DEVICE).
Who is sponsoring clinical trial NCT02232282?
This trial is sponsored by Loyola University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.